Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM
· Real-Time Price · USD
17.86
0.23 (1.30%)
At close: Aug 15, 2025, 10:01 AM
Beam Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 8.47M | 7.47M | 30.07M | 14.27M | 11.77M | 7.41M | 316.19M | 17.19M | 20.12M | 24.21M | 20.04M | 15.8M | 16.65M | 8.43M | 51.07M | 763K | 6K | 6K |
Cost of Revenue | 5.54M | n/a | n/a | n/a | 5.58M | 5.43M | 5.36M | 7.47M | 7.29M | 7M | 6.19M | 85.29M | 5.51M | 5.26M | 5.02M | 54.62M | 45.58M | 190.11M |
Gross Profit | 2.93M | 7.47M | -16.97M | 8.79M | 6.2M | 1.98M | 310.83M | 9.72M | 12.82M | 17.21M | 13.85M | -69.49M | 11.14M | 3.17M | 46.05M | -53.86M | -45.57M | -190.1M |
Operating Income | -120.15M | -119.29M | -100.04M | -106.5M | -104.89M | -104.13M | 132.86M | -108.27M | -102.15M | -98.93M | -88.98M | -91.3M | -81.97M | -76.22M | -63.48M | -69.63M | -58.97M | -200.37M |
Interest Income | 12.33M | n/a | 10.93M | 12.13M | n/a | 11.85M | 12.06M | 12.7M | 11.95M | 9.96M | 7.61M | 4.98M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -102.29M | -109.27M | -90.35M | -96.67M | -91.01M | -98.67M | 144.16M | -96.09M | -82.78M | -96.46M | -37.35M | -107.17M | -71.95M | -69.21M | -64.71M | -28.12M | -76.25M | -201.56M |
Net Income | -102.29M | -109.27M | -90.35M | -96.67M | -91.05M | -98.67M | 142.8M | -96.09M | -82.78M | -84.03M | -38.35M | -109.58M | -48.5M | -55.19M | -64.57M | -28.12M | -76.25M | -201.56M |
Selling & General & Admin | 21.32M | 27.94M | 28.66M | 26.52M | 24.05M | 21.29M | 37.9M | 25.41M | 24.66M | 23.49M | 22.68M | 21.82M | 24.06M | 19.25M | 17.77M | 15.77M | 13.4M | 10.27M |
Research & Development | 101.76M | 98.82M | 101.44M | 94.26M | 87.04M | 84.82M | 140.08M | 100.05M | 97.61M | 99.65M | 86.34M | 85.29M | 74.56M | 65.41M | 96.78M | 54.62M | 45.58M | 190.11M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -305K |
Operating Expenses | 123.08M | 126.76M | 130.1M | 120.77M | 111.09M | 106.11M | 177.97M | 125.46M | 122.26M | 123.14M | 109.02M | 107.1M | 98.62M | 84.66M | 114.55M | 70.4M | 58.98M | 200.38M |
Interest Expense | 12.33M | n/a | n/a | n/a | 14.19M | n/a | n/a | n/a | 11.95M | 9.96M | 7.61M | n/a | 2.06M | 644K | n/a | 9K | 52K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -5.58M | -5.43M | -5.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 128.62M | 126.76M | 130.1M | 120.77M | 116.67M | 111.54M | 183.33M | 125.46M | 122.26M | 123.14M | 109.02M | 107.1M | 98.62M | 84.66M | 114.55M | 70.4M | 58.98M | 200.38M |
Income Tax Expense | n/a | n/a | n/a | n/a | 39K | n/a | 1.37M | n/a | n/a | -12.43M | 1M | 2.41M | -23.45M | -14.02M | -134K | n/a | n/a | 882K |
Shares Outstanding (Basic) | 102M | 87.97M | 82.82M | 82.41M | 82.31M | 81.7M | 80.86M | 79.02M | 76.34M | 72.27M | 70.78M | 70.34M | 70.21M | 68.7M | 67.99M | 66.38M | 62.21M | 60.21M |
Shares Outstanding (Diluted) | 102M | 87.97M | 82.82M | 82.41M | 82.31M | 81.7M | 82.7M | 79.02M | 76.34M | 72.27M | 70.78M | 70.34M | 70.21M | 68.7M | 67.99M | 66.38M | 62.21M | 60.21M |
EPS (Basic) | -1 | -1.24 | -1.09 | -1.17 | -1.11 | -1.21 | 1.77 | -1.22 | -1.08 | -1.16 | -0.54 | -1.56 | -0.69 | -0.8 | -0.95 | -0.42 | -1.23 | -3.35 |
EPS (Diluted) | -1 | -1.24 | -1.09 | -1.17 | -1.11 | -1.21 | 1.73 | -1.22 | -1.08 | -1.16 | -0.54 | -1.56 | -0.69 | -0.8 | -0.95 | -0.42 | -1.23 | -3.35 |
EBITDA | -96.75M | -113.76M | -84.93M | -101.03M | -99.32M | -98.7M | 138.22M | -103.08M | -97.33M | -94.28M | -85.04M | -87.83M | -78.55M | -72.91M | -59.69M | -67.88M | -57.3M | -197.8M |
EBIT | -102.29M | -119.29M | -90.35M | -106.5M | -104.89M | -104.13M | 144.16M | -108.27M | -102.15M | -98.93M | -88.98M | -91.3M | -81.97M | -76.22M | -64.71M | -69.63M | -58.97M | -200.37M |
Depreciation & Amortization | 5.54M | 5.53M | 5.44M | 5.47M | 5.58M | 5.43M | 5.36M | 7.47M | 7.29M | 7M | 6.19M | 3.47M | 5.51M | 5.26M | 5.02M | 3.82M | 3.87M | 3.76M |